7,159 followers
A review of rrx-001: a late-stage multi-indication inhibitor of nlrp3 activation and chronic inflammation. - Jayabalan N et al. - https://t.co/DSyhCNUYH2 #microbiome
A review of rrx-001: a late-stage multi-indication inhibitor of nlrp3 activation and chronic inflammation. - Jayabalan N et al. - https://t.co/DSyhCNUYH2 #microbiome